Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Portuguese
  • Polish

Breadcrumb

  1. Home
  2. Gynecology
  3. Cervical cancer: the walls are closing in on L. iners
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gynecology
  3. Cervical cancer: the walls are closing in on L. iners
Gynecology

Cervical cancer: the walls are closing in on L. iners

Papillomavirus
Gynecology

According to a Chinese longitudinal study, a higher relative abundance of L. iners bacteria in the vagina reduces the chances of human papillomavirus (HPV) being cleared spontaneously twelve months after infection. This potential therapeutic target merits further exploration as part of the fight against cervical cancer.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail
Cancer du col de l’utérus : l’étau se resserre sur L. iners

About this article

Created 14 February 2023
Updated 09 March 2023

Sexual infection by a human papillomavirus (HPV) is common and is usually transitory, disappearing within 24 months in 80% of cases. However, for one in five women infection persists. High-risk human papillomavirus (HR-HPV) is the leading cause of cervical cancer.  Sexual activity, smoking, and oral contraception are among the many factors that influence initial infection, the resolution or the onset of HR-HPV, and potential progression to cancer. In recent years, the vaginal microbiota has been added to this list. The value of this study is therefore clear, since it monitored the cervical microbiota of HR-HPV infected Chinese women presenting histologically confirmed, and mostly low-grade, cervical lesions.

More L. iners, less spontaneous clearance

A 16S rRNA analysis of the microbiota of the 73 participants in the study (aged between 24 and 68 years) showed that HPV had disappeared in 45 of the women (61.6%) by the end of the twelve-month study period. The clearance or otherwise of the virus was not due to differences in the patients’ age, the stage of the disease, the HPV subtype, the (sidenote: Community state types Five types of vaginal community have been identified, four dominated by lactobacilli (Lactobacillus crispatus, L. gasseri, L. iners, and L. jensenii) and a fifth characterized by a low lactobacilli content. ) , or vaginal microbiota diversity. Instead, certain bacterial species seem to be involved: women depleted in enterococcus ASV_62 and enriched in Lactobacillus iners at baseline were less likely to have HPV-HR clearance at month twelve. The only exception was 22 women who underwent surgical treatment (conization) for high-grade lesions, perhaps because the immediate impact of lesion resection on HPV clearance masked the impact of the flora.

99 % of all cervical cancer cases are linked to infection with papillomavirus, an extremely common virus transmitted through sexual contact.

4th Cervical cancer is the fourth most common cancer in women.

570,000 women In 2018, an estimated 570,000 women were diagnosed with cervical cancer worldwide and about 311,000 women died from the disease.

Sources: WHO.

One more finger pointing at L. iners

A possible link between L. iners and HR-HPV had previously been reported by a meta-analysis suggesting a two- or even three-fold higher risk of persistent HR-HPV when the vaginal microbiota is dominated by L. iners. This bacterium appears to be both flexible and adaptable, dominating the vaginal microbiota of certain women during menstruation or episodes of bacterial vaginosis. On the other hand, a vaginal microbiota dominated by L. iners (CST III) is frequently reported as one of the most common types of vaginal bacterial community among Asian child-bearing age women. Therefore, it is not yet clear from the current literature whether this particular strain of Lactobacillus should be considered beneficial, pathogenic, or both. Further work is also needed to clarify the mechanisms by which L. iners promotes persistent HPV infection or lesion progression, especially since the current study involved a small number of patients, certain confounding factors, such as smoking, were not taken into account, and it lasted only one year, whereas a 24-month follow-up is required.

Sources

Shi W, Zhu H, Yuan L et al. Vaginal microbiota and HPV clearance: A longitudinal study. Front Oncol. 2022 Oct 24;12:955150.

Tags
Papillomavirus Vagina Cancer Uterus Cervical Cancer

en_view en_sources

    See also

    Vaginal microbiota # 14
    Cervicovaginal microbiota: a marker for persistent papillomavirus infection?
    Created 14 February 2023
    Updated 09 March 2023

    About this article

    To know more about this topic.

    Main topic

    Papillomavirus

    Medical practice

    Gynecology

    Content type

    News
    Gynecology

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Vaginal Microbiota # 16

    By Pr. Satu PekkalaAcademy of Finland Research Fellow, Faculty of Sport and Health Sciences, University of ...

    Find out more

    Vaginal microbiota # 14

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Vaginal Microbiota #15

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Urinary tract infections

    Infections of the lower urogenital tract are extremely common amongst women: seven out of ten women will su...

    Find out more

    Vaginal microbiota #10

    By Pr. Markku VoutilainenTurku University Faculty of Medicine; Turku University Hospital, Department of Gas...

    Find out more

    Targeting the gut microbiota to optimize vaccine efficacy?

    by Dr Genelle Healey

    Find out more

    The hygiene hypothesis and the COVID-19 pandemic

    by Dr Genelle Healey

    Find out more

    Continue reading

    News
    Pregnancy: is vaginal dysbiosis responsible for complications in case of COVID-19?
    06.01.2023

    Pregnancy: is vaginal dysbiosis responsible for complications in case of COVID-19?

    Read the article
    Photo: WAAW 2022 (HCPs)
    25.10.2022

    Microbiota at the forefront of antibiotic resistance

    Read the article
    25.10.2022

    Antibiotics: Dr Jekyll and Mr Hyde

    Read the article
    Everything you need to know about Microbiota & Dysbiosis
    27.07.2022

    Everything you need to know about Dysbiosis

    Read the article
    Photo: Antibiotic resistance is a web of several problems (HCPs)
    02.11.2022

    Antibiotic resistance is a web of several problems

    Read the article
    Actu PRO : Une antibiothérapie prophylactique péri-partum appauvrit le lait maternel en Bifidobacterium
    12.03.2019

    Peripartum prophylactic antibiotic therapy decreases bifidobacterium levels in breast milk

    Read the article
    28.10.2021

    6 things you should know about antibiotics

    Read the article
    28.10.2021

    Antimicrobial resistance: a global threat, an international response

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Portuguese
    • Polish

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    14.03.2023

    Positive impact of running on gut microbiota and adolescent depression

    Read the article
    09.03.2023

    Each subtype of Irritable Bowel Syndrome (IBS) has its own dysbiosis

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo